Sentences with phrase «cardiovascular event risk»

Data from 16,718 women who weren't taking personal calcium supplements at the beginning of the study was analysed and it was revealed that those allocated to a vitamin D and calcium supplement combination had an increased cardiovascular event risk, particularly heart attack.

Not exact matches

GOOGLE»S AI HELPS TO PREDICT CARDIOVASCULAR CONDITIONS BY ANALYZING EYE SCANS: Google and Verily — Google - parent Alphabet's life sciences unit — are exploring new ways that artificial intelligence (AI) can be used to identify patients» risk of suffering from a cardiovascular event, such as a heart attack or stroke, according to a newly published study by the two AlphabetCARDIOVASCULAR CONDITIONS BY ANALYZING EYE SCANS: Google and Verily — Google - parent Alphabet's life sciences unit — are exploring new ways that artificial intelligence (AI) can be used to identify patients» risk of suffering from a cardiovascular event, such as a heart attack or stroke, according to a newly published study by the two Alphabetcardiovascular event, such as a heart attack or stroke, according to a newly published study by the two Alphabet subsidiaries.

that individual's risk of suffering a cardiovascular event with comparable accuracy to current leading methods.

High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real - world analysis of statin - treated patients with high cardiovascular risk and well - controlled low - density lipoprotein cholesterol [abstract].

Leading clinical investigations seeking to address cardiovascular risk reduction beyond lowering LDL - C focus on interrupting the atherosclerotic process (e.g., plaque formation and instability) by beneficially affecting other lipid, lipoprotein and inflammation biomarkers and cellular functions thought to be related to atherosclerosis and cardiovascular events.

People with type 2 diabetes are at high risk of cardiovascular - related events, such as heart attacks, stroke, and even death, often because their levels of triglycerides are so high, and their high - density lipoprotein (HDL) cholesterol levels are low.

A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of «good» cholesterol, despite being treated with statins.

The trial found that rosuvastatin reduced the risk of cardiovascular events by 44 percent as compared with placebo.

Bococizumab significantly reduces cardiovascular events in high - risk patients with high LDL cholesterol levels.

Researchers report that bococizumab had short - term benefits on lowering cholesterol levels and significantly reduced the risk of cardiovascular events by 21 percent compared to placebo among those who had baseline LDL cholesterol levels of greater than 100 mg / dL.

Still, previous studies have associated abdomen fat to higher risks of cancer, cardiovascular events and death.

That analysis of published large randomized trials calculated that each 77 - point drop in LDL cholesterol (a 2 millimole per liter drop) reduced the risk of a major cardiovascular event — heart attack, stroke or the need for a coronary - clearing procedure — by 45 percent.

(By including people who had vascular disease, the Lancet meta - analysis overestimated statins» benefits: a subgroup analysis reveals that among people who did not have vascular disease, statins only reduced the absolute risk of a cardiovascular event by 0.4 percent per year.)

The piece based its recommendation on a meta - analysis of 27 clinical trials published in the same issue that concluded statins significantly reduce the risk of heart attacks and other cardiovascular events in healthy people without posing substantial risks.

He also says these results add to the growing understanding of the additional risks associated with severe psoriasis, which Gelfand's other studies have shown can include major cardiovascular events, liver disease and death.

«Healthy patients with elevated calcium and plaque burden are at increased risk of experiencing adverse cardiovascular events in even a short period of just three years.»

«Our study shows simply adding one of our available cardiac imaging resources may more accurately predict a patient's risk or diagnose their disease, also giving us an opportunity to prevent them from experiencing a future cardiac event and possibly save more lives from the burdens of cardiovascular diseases.»

The authors explain that this difference is due to the fact that age has a much greater effect than age at diagnosis on the risk of cardiovascular events and death.

«Our analysis suggests that migraine should be considered an important risk marker for cardiovascular disease, particularly in women,» concludes Prof. Kurth, adding that: «The risk of developing cardiovascular events was shown to be 50 % higher in women with a diagnosis of migraine.

People receiving the placebo had about a 4.5 % risk of a second cardiovascular event after a year versus 3.86 % for those on the medium dose of the drug.

«If we had just done traditional risk factor assessments, we would have missed each one of those firefighters who we discovered were at risk for a cardiovascular event,» says study leader Elizabeth V. Ratchford, M.D., an assistant professor of medicine at the Johns Hopkins University School of Medicine and director of the Johns Hopkins Center for Vascular Medicine.

M. Dominique Ashen, Ph.D., C.R.N.P., a nurse practitioner in the Ciccarone Center for the Prevention of Heart Disease at Johns Hopkins and another study leader, says that a traditional risk assessment for cardiovascular disease involves checking blood pressure, cholesterol levels and weight; evaluating for diabetes; taking a family history; calculating the 10 - year risk of having a cardiovascular event; and asking about lifestyle factors such as smoking, diet and exercise.

It is likely the combination therapy will reduce the risk of recurrent cardiovascular events by well over two - thirds,» said Yusuf.

Although aspirin reduces the risk of major cardiovascular events by 19 per cent, a more effective antithrombotic strategy could have major benefits for the large population of patients with stable cardiovascular disease.

«We are here to help them understand that prevention of cardiovascular disease is important and that the earlier we identify risk factors for cardiovascular disease or plaque in their arteries, the sooner we can work to reduce the risk of a major cardiovascular event, such as heart attack,» Ashen says.

Patients with low testosterone levels who have then gone on to have testosterone replacement therapy (TRT) could be at lower risk of cardiovascular events such as heart attack or stroke, according to research published in the European Heart Journal.

A new study suggests men who engaged in frequent sauna use had reduced risks of fatal cardiovascular events and all - cause mortality, according to an article published online by JAMA Internal Medicine.

«It is important to remember that hormonal substitution, when taken at the beginning of menopause and for a few years only, does not cause any particular risk of cardiovascular events,» stresses Jacques Philippe.

An antibody used to treat the skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.

Large observational studies report that in severely obese individuals, bariatric surgery is associated with long - term reductions in all major cardiovascular disease (CVD) risk factors, CVD events such as heart attacks and strokes, cancer and all - cause mortality, including a 92 % decrease in diabetes - related deaths.

The team, led by Dr Jacob George, Senior Clinical Lecturer and Honorary Consultant in Clinical Pharmacology at the University of Dundee, compared the risk of cardiovascular events (non-fatal heart attack, non-fatal stoke, or vascular death) in patients taking sodium - containing effervescent, dispersible and soluble medications with those taking non-sodium versions of the same drugs between 1987 and 2010.

The study authors wanted to know to what extent the risks of cardiovascular events for diabetic women differed with various types of hormonal birth control.

«Our study has several distinct strengths compared to prior studies including the large number of participants, long - term follow - up, large number of cardiovascular events that were confirmed by medical record review, detailed information about diet and other cardiovascular disease risk factors, and repeated assessment of calcium supplement use over the 24 - year follow up period,» said Julie Paik, MD, MPH, BWH Channing Division of Network Medicine, Department of Medicine, lead study author.

(For the general population of women in the study, the researchers found that long - term exposure to air pollution led to small, but not statistically significant, increases in risk of cardiovascular events.)

Severe OSA is associated with an increased risk of death, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life and motor vehicle crashes.

These findings are similar to those of an earlier, multicenter study that found the risk of a major cardiovascular event more than doubled in patients with the genetic mutations who took clopidogrel.

The panel recognizes the value of several new features in the guideline, such as specific risk equations for African - Americans, equations to calculate both 10 - year and 30 - year lifetime risk, inclusion of stroke as an adverse cardiovascular event, and emphasis on shared decision - making.

«We do show that obstructive coronary artery disease and myocardial ischemia remain the strongest predictors of future cardiovascular events, but for the first time, in a randomized comparison we demonstrate the ability of CT angiography (CTA) to identify a large group of at - risk patients who would have been missed by functional stress testing,» says Hoffmann, who is director of the MGH Cardiac MR PET CT Program.

«Young women who survive cardiovascular event have long - term risks.»

That's more than 5 times the risk of death seen in the patients who had no additional non-fatal cardiovascular event while in the study.

After adjusting the data for age, sex, race, education, smoking, alcohol use, blood pressure, diabetes, high blood pressure medication, cholesterol levels, statin use and body mass index, the researchers found that those people who met both the recommended activity levels and had vitamin D levels above 20 nanograms per milliliter experienced about a 23 percent less chance of having an adverse cardiovascular event than those people with poor physical activity who were deficient for vitamin D. On the other hand, people who had adequate exercise but were vitamin D deficient didn't have a reduced risk of an adverse event.

A two - drug antihypertensive treatment that included a beta - blocker was associated with increased risk for major adverse cardiovascular events (MACEs) and death in a study of Danish patients who underwent noncardiac surgery, according to an article published online by JAMA Internal Medicine.

Cardiovascular phenotyping between the ages of 60 and 64 years with carotid intima media thickness (cIMT; a surrogate marker for cardiovascular events) was used to assess the effect of lifetime exposure to adiposity on cardiovascular risk factors.

The first such drug, torcetrapib, was abandoned after a phase 3 clinical trial revealed it increased the risk of cardiovascular events and death.

The Physicians» Health Study II (PHS II) remains the only randomized, large - scale, long - term trial to test whether a daily multivitamin reduced cardiovascular disease risk, and researchers found that after 11 years of follow up, there was no significant difference in risk of major cardiovascular disease (CVD) events among men who took a multivitamin compared to those that took a placebo.

«This increased risk of adverse cardiovascular events is about the same level as that seen in people who develop reduced blood flow in the heart muscle during a conventional test, such as a treadmill stress test.»

But our findings suggest that all CAD patients should receive statins to reduce their risk of future cardiovascular events.»

Weight gain after liver transplantation can lead to serious complications and increase the risk of post-transplant metabolic syndrome, cardiovascular events, and kidney failure.

CCTA is likely to be valuable for other groups of patients at high risk for cardiovascular events, the researchers said, and may one day enable physicians to predict plaque development and treat it aggressively before PVI increases significantly.

Imaging of the coronary arteries with computed tomography (CT) angiography provides an accurate assessment of arterial plaque and could have a dramatic impact on the management of diabetic patients who face a high risk of heart attacks and other cardiovascular events, according to a new multicenter study published online in the journal Radiology.